Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,247 total articles
The article details an insider transaction involving Mark S. Silver, Executive Vice President and Chief Legal/Risk Officer at Ryerson Holding Corp (NYSE:RYZ). Mr. Silver sold 11,174 shares totaling $311,842 in late May 2026. This activity occurs as the stock has seen a significant increase over the past year. Separately, Ryerson Holding Corp recent…
The President of Research & Development at Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), David Young, recently acquired a significant block of company stock. On May 29, 2026, Mr. Young purchased 1,786 shares of common stock for a total investment of $4,590. This transaction occurred when the per-share price was $2.57, which was slightly higher than…
Patrick Lin, Chief Business and Strategy Officer of Processa Pharmaceuticals, Inc. (PCSA), recently purchased additional common stock, an action that some analysts interpret as a reflection of internal confidence. The acquisition occurred while the company's stock was trading close to its recent low point.
Wendy Guy, Chief Administrative Officer at Processa Pharmaceuticals, Inc., recently acquired a block of shares in the company. The purchase occurred on May 29, 2026. This insider transaction is noteworthy given that the stock has experienced a significant decline over the past six months, though current analysis suggests potential undervaluation.
John T. Treace, a principal officer and director of TREACE MEDICAL CONCEPTS, INC., recently acquired a significant block of the company's common stock. This transaction occurred while the stock was experiencing substantial gains. Furthermore, recent corporate disclosures included financial results for the first quarter of 2026 that surpassed analys…
Robert D. Fatovic, an executive at Ryder System Inc., sold a significant block of common stock on May 29, 2026. This transaction occurred while the company's stock price was near its 52-week high and shortly after reporting Q1 2026 earnings that beat profit estimates but slightly missed revenue forecasts.
Bettina Deynes, Chief Human Resources Officer at Carnival Corp Ltd., sold a significant block of common shares. This transaction occurs against a backdrop of several positive corporate developments for the company, including a dividend announcement, structural unification, and favorable analyst actions that suggest potential undervaluation.
The Chief Legal Officer of Precigen Inc. recently sold a portion of company stock in a transaction defined as 'sell-to-cover.' This activity occurred against a backdrop of strong corporate performance, including Q1 2026 earnings that beat expectations, and significant regulatory news regarding the drug PAPZIMEOS.
Genworth Holdings sold a substantial block of shares in its investment, Enact Holdings. This transaction occurred while Enact reported mixed first-quarter earnings for 2026. Although the company surpassed consensus estimates for adjusted earnings per share (EPS), revenue fell below anticipated levels, prompting analysts to adjust price targets.
The Chief Executive Officer of Precigen, Inc., Helen Sabzevari, recently sold a significant block of company stock. This transaction occurred as the firm reported strong first-quarter financial results, including an earnings per share (EPS) figure that surpassed analyst expectations. Furthermore, the company secured a seven-year market advantage fo…
A recent transaction involving director Wilfred T. O’Gara saw the sale of 10,369 common shares of LSI Industries Inc. (NASDAQ:LYTS) on June 1, 2026. The total value realized from this sale was $249,789, with each share priced at $24.09.This transaction occurred after a strong performance period for the company, which has seen its shares deliver a 5…
Covenant Logistics Group reported robust Q1 2026 financial results, with revenue exceeding expectations. This positive performance coincided with an executive selling a portion of his holdings, while external analysts raised price targets based on improvements in the truck market sector. The company also declared a quarterly dividend.
Ross Kade, Chief Information Officer at Bandwidth Inc., recently sold a portion of his company shares following the vesting of Restricted Stock Units (RSUs). This insider activity occurred against a backdrop of strong Q1 2026 earnings reports for Bandwidth, which beat analyst expectations. Despite the stock trading near its 52-week high and being f…
Devin M. Krupka, the Controller and Principal Accounting Officer at Bandwidth Inc., executed multiple sales of company stock totaling 1,198 shares valued at $70,496 on May 29, 2026. These transactions occurred while the stock was trading near its recent highs. The selling activity is noted against a backdrop of robust corporate performance, includi…
Jack Abuhoff, the Chief Executive Officer of Innodata Inc., executed a significant sale of common stock totaling approximately $10.9 million on May 29, 2026, following the exercise of his vested options. This activity occurs as Innodata shares trade near their recent 52-week high. The report also details that the company recently reported strong fi…
A director of Richmond Mutual Bancorporation, Inc., Blum E. Michael, recently acquired a block of common stock. This activity occurs against a backdrop of corporate development, including the announcement of a quarterly cash dividend and progress updates regarding the potential merger with The Farmers Bancorp of Frankfort, Indiana.
Chief Legal Officer Deborah Ann Miller sold a significant block of shares in Nuvalent, Inc. (NASDAQ:NUVL) via an established trading plan. This insider activity is reported alongside substantial positive developments regarding the company's drug pipeline, including the FDA granting Priority Review to neladalkib and presentation of updated data for …
Chief Commercial Officer Phil Tennant sold a portion of his holdings in PRECIGEN, INC. (PGEN) following vesting of restricted stock units. This transaction occurs amidst significant operational developments for the company, including better-than-expected Q1 2026 earnings and the granting of orphan drug exclusivity for PAPZIMEOS.
Independent Bank Corp. (INDB) reported robust first-quarter financial results, with revenue significantly exceeding consensus estimates. Concurrently, Joseph C. Lerner, a director at the bank, executed a transaction selling a notable block of company common stock, which was noted in recent filings. The sale occurred amidst reports detailing the ins…
Figure Technology Solutions CFO Kgil Minchung sold a substantial block of company shares, while the firm simultaneously released Q1 2026 earnings that beat analyst expectations on both profit and revenue. The report details executive trading activity alongside significant operational performance metrics.
The recent SEC filing revealed that Harry Thomasian Jr., Chief Financial Officer of Precigen, Inc. (PGEN), sold shares totaling $182,614 on May 28, 2026. This sale was specifically categorized as a 'sell-to-cover' transaction to satisfy tax withholding requirements related to the vesting of restricted stock units that occurred on May 23, 2026. Sepa…
The Chief Operating Officer of Precigen, Inc., Rutul R. Shah, recently sold a portion of his company stock in a tax-related transaction. This activity occurs against a backdrop of positive corporate developments, including exceeding market expectations for Q1 2026 earnings and securing significant drug exclusivity for PAPZIMEOS.
Executive Vice President and Chief Financial Officer James E. Galeese sold approximately $3.32 million worth of common shares in LSI Industries Inc. (NASDAQ:LYTS) following the exercise of stock options. This transaction occurred while the company reported strong operational results for its third quarter of fiscal 2026, with revenues surpassing ana…
A key insider transaction was reported involving a director of Total Return Securities Fund (SWZ). Moritz A. Sell purchased shares, adding to his existing holdings as the stock trades near its recent low point. The report details the acquisition amount and Mr. Sell's total current stake in the company.
Illumina's VP and Chief Accounting Officer executed stock sales in late May. This activity occurred against a backdrop of significant corporate developments, including a collaboration with Integrated DNA Technologies to boost oncology research, the launch of new sequencing kits, and positive rating adjustments from major financial institutions.
